PTC THERAPEUTICS, INC. (PTCT)

Latest Insider Confidence Score

2026Q1

42.7
Bearish

Company insider confidence (by quarter)

2014Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Klein Matthew B. CEO 353,392 Dec 3, 2025
Kovacs Shane William Charles CFO 264,484 May 11, 2017
Golden Lee Scott EVP & CHIEF MEDICAL OFFICER 75,997 Apr 4, 2025
Gravier Pierre CFO 71,920 Jul 17, 2025
Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER 62,564 Feb 21, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 19, 2026 Feb 23, 2026 Boulding Mark Elliott EXEC. VP AND CLO Sell 42.5 -3,019 -2.79% ✓ $209.8K
Feb 18, 2026 Feb 20, 2026 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sell 42.5 -2,494 -3.43% ✗ $173K
Feb 18, 2026 Feb 20, 2026 Gravier Pierre CFO Sell 42.5 -2,992 -3.31% ✗ $207.5K
Feb 18, 2026 Feb 20, 2026 Pauwels Eric CHIEF BUSINESS OFFICER Sell 42.5 -3,019 -3.77% ✗ $209.4K
Feb 18, 2026 Feb 20, 2026 Klein Matthew B. CEO Sell 40.0 -7,371 -1.87% ✗ $511.3K
Feb 18, 2026 Feb 20, 2026 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sell 42.5 -2,484 -2.69% ✗ $172.3K
Feb 18, 2026 Feb 20, 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 42.5 -3,121 -2.56% ✗ $216.5K
Feb 17, 2026 Feb 19, 2026 Boulding Mark Elliott EXEC. VP AND CLO Sell 32.5 -5,894 -5.16% ✓ $408.6K
Jan 8, 2026 Jan 12, 2026 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sell 42.5 -1,034 -1.40% ✗ $79K
Jan 8, 2026 Jan 12, 2026 Pauwels Eric CHIEF BUSINESS OFFICER Sell 28.8 -7,348 -8.40% ✓ $565.9K
Jan 8, 2026 Jan 12, 2026 Klein Matthew B. CEO Sell 45.0 -2,514 -0.63% ✗ $192.2K
Jan 8, 2026 Jan 12, 2026 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sell 45.0 -866 -0.93% ✗ $66.2K
Jan 8, 2026 Jan 12, 2026 Boulding Mark Elliott EXEC. VP AND CLO Sell 32.5 -6,347 -5.39% ✓ $489.1K
Jan 8, 2026 Jan 12, 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 45.0 -940 -0.76% ✗ $71.9K
Jan 6, 2026 Jan 8, 2026 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sell 42.5 -2,616 -3.43% ✗ $201.9K
Jan 6, 2026 Jan 8, 2026 Gravier Pierre CFO Sell 42.5 -2,139 -2.31% ✗ $164.6K
Jan 6, 2026 Jan 8, 2026 Pauwels Eric CHIEF BUSINESS OFFICER Sell 42.5 -3,141 -3.47% ✗ $242.4K
Jan 6, 2026 Jan 8, 2026 Klein Matthew B. CEO Sell 40.0 -8,165 -2.02% ✗ $629.9K
Jan 6, 2026 Jan 8, 2026 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sell 42.5 -1,982 -2.08% ✗ $152.9K
Jan 6, 2026 Jan 8, 2026 Boulding Mark Elliott EXEC. VP AND CLO Sell 47.5 -6,618 -0.70% ✓ $511.6K
Jan 6, 2026 Jan 8, 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 42.5 -2,411 -1.92% ✗ $186.1K
Jan 2, 2026 Jan 6, 2026 Smith Mary L. Director Neutral 90.0 +4,000 22.46% ✗ -
Jan 2, 2026 Jan 6, 2026 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Neutral 90.0 +18,020 16.79% ✗ -
Jan 2, 2026 Jan 6, 2026 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Neutral 90.0 +13,250 21.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Neutral 90.0 +18,750 24.50% ✗ -
Jan 2, 2026 Jan 6, 2026 Pauwels Eric CHIEF BUSINESS OFFICER Neutral 90.0 +20,000 28.32% ✗ -
Jan 2, 2026 Jan 6, 2026 Boulding Mark Elliott EXEC. VP AND CLO Sell 87.5 +14,734 3.13% ✓ $171.2K
Jan 2, 2026 Jan 6, 2026 Reeve Emma Director Sell 95.0 +3,266 18.08% ✓ $55.8K
Jan 2, 2026 Jan 6, 2026 ZELDIS JEROME B Director Neutral 90.0 +4,000 21.62% ✗ -
Jan 2, 2026 Jan 6, 2026 Young Alethia Director Neutral 90.0 +4,000 23.44% ✗ -
Jan 2, 2026 Jan 6, 2026 SOUTHWELL DAVID P Director Neutral 90.0 +4,000 23.74% ✗ -
Jan 2, 2026 Jan 6, 2026 Okey Stephanie Director Neutral 90.0 +4,000 50.00% ✗ -
Jan 2, 2026 Jan 6, 2026 Jacobson Allan Steven Director Neutral 90.0 +4,000 22.92% ✗ -
Jan 2, 2026 Jan 6, 2026 SCHMERTZLER MICHAEL Director Neutral 85.0 +8,000 5.15% ✗ -
Jan 2, 2026 Jan 6, 2026 Gravier Pierre CFO Neutral 90.0 +20,000 27.61% ✗ -
Jan 2, 2026 Jan 6, 2026 Klein Matthew B. CEO Neutral 90.0 +63,000 18.41% ✗ -
Jan 2, 2026 Jan 6, 2026 STEELE GLENN JR MD PHD Director Sell 10.0 -8,000 -26.23% ✓ $916.2K
Dec 30, 2025 Jan 2, 2026 Klein Matthew B. CEO Sell 40.0 -8,089 -2.31% ✗ $619.9K
Dec 19, 2025 Dec 23, 2025 Pauwels Eric CHIEF BUSINESS OFFICER Sell 40.0 -20,508 -2.70% ✓ $1.6M
Dec 17, 2025 Dec 19, 2025 Pauwels Eric CHIEF BUSINESS OFFICER Sell 27.5 -43,492 -7.14% ✓ $3.3M
Dec 16, 2025 Dec 18, 2025 SCHMERTZLER MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Dec 3, 2025 Dec 5, 2025 Reeve Emma Director Sell 28.8 -733 -9.91% ✓ $57.6K
Dec 1, 2025 Dec 3, 2025 Klein Matthew B. CEO Sell 90.0 +12,197 3.61% ✗ $271.1K
Nov 25, 2025 Nov 26, 2025 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 31.3 -71,928 -3.49% ✓ $6M
Nov 24, 2025 Nov 26, 2025 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 27.5 -35,572 -6.53% ✓ $2.9M
Nov 24, 2025 Nov 26, 2025 Jacobson Allan Steven Director Sell 20.0 -26,000 -12.12% ✓ $2.1M
Nov 21, 2025 Nov 25, 2025 Reeve Emma Director Sell 7.5 -10,000 -60.00% ✓ $795K
Nov 20, 2025 Nov 21, 2025 Okey Stephanie Director Neutral 27.5 -867 -9.78% ✗ -
Nov 17, 2025 Nov 19, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 41.3 -2,812 -2.64% ✓ $213.7K
Nov 12, 2025 Nov 14, 2025 Reeve Emma Director Sell 7.5 -7,333 -52.38% ✓ $546.3K
Oct 30, 2025 Oct 31, 2025 Reeve Emma Director Sell 5.0 -15,666 -54.02% ✓ $1.1M
Oct 7, 2025 Oct 9, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 37.5 -3,375 -3.15% ✓ $214.1K
Oct 3, 2025 Oct 7, 2025 Reeve Emma Director Sell 15.0 -25,562 -17.99% ✓ $1.7M
Oct 3, 2025 Oct 7, 2025 Jacobson Allan Steven Director Sell 7.5 -12,000 -40.75% ✓ $780K
Oct 3, 2025 Oct 7, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 36.3 -24,921 -2.08% ✓ $1.6M
Oct 3, 2025 Oct 7, 2025 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 23.8 -55,000 -7.87% ✓ $3.6M
Sep 11, 2025 Sep 16, 2025 Reeve Emma Director Sell 7.5 -15,705 -26.91% ✓ $934.4K
Sep 11, 2025 Sep 15, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 27.5 -47,249 -6.10% ✓ $2.9M
Sep 9, 2025 Sep 11, 2025 SOUTHWELL DAVID P Director Sell 20.0 -12,000 -41.59% ✗ $700.1K
Sep 8, 2025 Sep 9, 2025 Pauwels Eric CHIEF BUSINESS OFFICER Sell 27.5 -39,850 -7.24% ✓ $2.3M
Aug 28, 2025 Sep 2, 2025 Jacobson Allan Steven Director Sell 22.5 -1,667 -8.72% ✗ $83.6K
Aug 15, 2025 Aug 19, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 41.3 -2,813 -2.64% ✓ $136.7K
Aug 1, 2025 Aug 5, 2025 Klein Matthew B. CEO Sell 97.5 +64,261 23.50% ✗ $555.6K
Jul 15, 2025 Jul 17, 2025 Gravier Pierre CFO Sell 42.5 -2,516 -3.38% ✗ $124.4K
May 15, 2025 May 19, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 45.0 -2,812 -1.34% ✓ $129.7K
Apr 22, 2025 Apr 24, 2025 Klein Matthew B. CEO Sell 42.5 -2,804 -1.02% ✗ $136.7K
Apr 2, 2025 Apr 4, 2025 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sell 46.3 -897 -1.17% ✗ $42.1K
Mar 14, 2025 Mar 18, 2025 Pauwels Eric CHIEF BUSINESS OFFICER Sell 22.5 -11,220 -13.38% ✓ $630.1K
Mar 13, 2025 Mar 17, 2025 Okey Stephanie Director Sell 20.0 -5,000 -36.06% ✗ $270K
Mar 12, 2025 Mar 14, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 30.0 -15,521 -6.95% ✓ $827.2K
Mar 10, 2025 Mar 12, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 20.0 -75,420 -10.67% ✓ $4M
Mar 4, 2025 Mar 6, 2025 Jacobson Allan Steven Director Sell 22.5 -1,230 -6.04% ✗ $63.4K
Feb 19, 2025 Feb 21, 2025 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sell 42.5 -1,757 -2.73% ✗ $88K
Feb 19, 2025 Feb 21, 2025 Gravier Pierre CFO Sell 42.5 -2,335 -3.04% ✗ $117K
Feb 19, 2025 Feb 21, 2025 Pauwels Eric CEO Sell 42.5 -2,945 -3.39% ✗ $147.6K
Feb 19, 2025 Feb 21, 2025 Klein Matthew B. CEO Sell 40.0 -7,792 -2.75% ✗ $390.5K
Feb 19, 2025 Feb 21, 2025 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sell 42.5 -1,757 -2.23% ✗ $88K
Feb 19, 2025 Feb 21, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 42.5 -2,947 -2.76% ✗ $147.7K
Feb 19, 2025 Feb 21, 2025 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 42.5 -2,946 -2.70% ✗ $147.6K
Jan 7, 2025 Jan 10, 2025 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sell 42.5 -2,953 -4.39% ✗ $132.5K
Jan 7, 2025 Jan 10, 2025 Pauwels Eric CEO Sell 42.5 -3,735 -4.13% ✗ $167.6K
Jan 7, 2025 Jan 10, 2025 Klein Matthew B. CEO Sell 42.5 -4,544 -1.58% ✗ $204K
Jan 7, 2025 Jan 10, 2025 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Sell 42.5 -2,008 -2.49% ✗ $90K
Jan 7, 2025 Jan 10, 2025 Boulding Mark Elliott EXEC. VP AND CLO Sell 42.5 -3,541 -3.21% ✗ $158.9K
Jan 7, 2025 Jan 10, 2025 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sell 42.5 -2,979 -2.66% ✗ $133.7K
Jan 3, 2025 Jan 7, 2025 Young Alethia Director Neutral 90.0 +4,000 30.61% ✗ -
Jan 3, 2025 Jan 7, 2025 ZELDIS JEROME B Director Neutral 90.0 +4,000 27.59% ✗ -
Jan 3, 2025 Jan 7, 2025 STEELE GLENN JR MD PHD Director Neutral 90.0 +4,000 27.59% ✗ -
Jan 3, 2025 Jan 7, 2025 SOUTHWELL DAVID P Director Neutral 90.0 +4,000 27.59% ✗ -
Jan 3, 2025 Jan 7, 2025 Smith Mary L. Director Neutral 90.0 +4,000 28.96% ✗ -
Jan 3, 2025 Jan 7, 2025 Reeve Emma Director Neutral 90.0 +4,000 35.71% ✗ -
Jan 3, 2025 Jan 7, 2025 Okey Stephanie Director Neutral 90.0 +4,000 40.54% ✗ -
Jan 3, 2025 Jan 7, 2025 Jacobson Allan Steven Director Neutral 90.0 +4,000 24.47% ✗ -
Jan 3, 2025 Jan 7, 2025 SCHMERTZLER MICHAEL Director Neutral 85.0 +8,000 6.49% ✗ -
Jan 3, 2025 Jan 7, 2025 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Neutral 90.0 +14,000 26.28% ✗ -
Jan 3, 2025 Jan 7, 2025 Boulding Mark Elliott EXEC. VP AND CLO Neutral 90.0 +18,000 19.48% ✗ -
Jan 3, 2025 Jan 7, 2025 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Neutral 90.0 +19,715 21.32% ✗ -
Jan 3, 2025 Jan 7, 2025 Golden Lee Scott EVP & CHIEF MEDICAL OFFICER Neutral 90.0 +20,000 32.97% ✗ -
Jan 3, 2025 Jan 7, 2025 Pauwels Eric CEO Neutral 90.0 +22,000 32.10% ✗ -
Jan 3, 2025 Jan 7, 2025 Gravier Pierre CFO Neutral 90.0 +22,500 41.46% ✗ -